Submitted by mphilemon@resea... on Tue, 03/29/2011 - 10:11
-
Cancer Educators Slide Library:
Prostate Cancer Update Think Tank Edition – 2011Video Module I: Screening Recommendations and Risk Assessment Strategies
Dr Judd W Moul reviews current screening recommendations and practical strategies to refine risk assessment after initial diagnosis. -
Video Module II: Controversies in the Management of PSA-Only Recurrent Disease
Dr Stephen J Freedland discusses controversies on the timing and selection of therapy in the management of PSA-only recurrent disease and the ongoing clinical trials for this patient population. -
Video Module III: Novel Targeted Therapeutics
Dr Robert Dreicer provides an overview on promising novel agents in late-stage clinical trials for the treatment of castration-resistant metastatic prostate cancer. -
Video Module IV: Bone-Directed Therapy
Dr Matthew R Smith discusses the role of bone health with extended or intermittent androgen deprivation therapy and the efficacy of systemic bone-directed treatments for patients with skeletal metastases. -
Video Module V: Radiation Therapy with Concurrent Androgen Deprivation Therapy
Featuring Dr Howard Sandler, this program highlights radiation therapy (external or brachytherapy) with concurrent short-term or long-term androgen deprivation therapy. -
Video Module VI: Chemotherapy
Dr A Oliver Sartor discusses the efficacy and current placement of first-line docetaxel-based chemotherapy and provides an introduction to the use of cabazitaxel for castration-resistant prostate cancer. -
Video Module VII: Immunotherapy
Dr Philip Kantoff summarizes the existing data and ongoing clinical trials on immunotherapy and discusses the pivotal data supporting the possible integration of vaccine therapy to treat castration-resistant prostate cancer.